IAM — Iambic Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1997038 ·
Last close
$23.81
Market Cap
—
52W High
$25.00
52W Low
$16.15
ADV30
2,476,850
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $233.82B | $432.49 | — |
| GILD | GILEAD SCIENCES, INC. | $193.67B | $156.19 | — |
| MRNA | Moderna, Inc. | $87.04B | $218.01 | — |
| ARGX | ARGENX SE | $50.94B | $819.14 | — |
| RVMD | Revolution Medicines, Inc. | $38.14B | $177.96 | — |
News headlines (Yahoo Finance, 1h cache)
Iambic Therapeutics (IAM) Filed An IND For IAM217
2026-10-18 05:15 · Yahoo
Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?
2026-10-18 00:16 · Yahoo
Another Biotech IPO Pops on Rough Day for Broader Market
2026-10-16 17:46 · Yahoo
Cathie Wood-Backed Biotech IPO Pops in Debut
2026-10-15 17:38 · Yahoo
Iambic Announces Pricing of Initial Public Offering
2026-10-14 22:52 · Yahoo
Toogood Gold Narrows Table Mountain Targets as Two Major Gold Corridors Take Shape
2026-09-28 15:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.